# Development of a Starvation Response–Based Model and Its Application in Prognostic Assessment of Liver Hepatocellular Carcinoma

**Authors:** Xinjun Hu, Yafeng Liu, Shujun Zhang, Kaijie Liu, Xinyu Gu

PMC · DOI: 10.1155/mi/8828435 · Mediators of Inflammation · 2025-07-07

## TL;DR

This study develops a new model based on starvation response genes to predict the prognosis of liver cancer, identifying key genes that influence tumor growth and immune response.

## Contribution

The study introduces the first risk model based on starvation response-related genes for accurate prognosis prediction in liver hepatocellular carcinoma.

## Key findings

- Five independent prognostic genes (FBXL5, PON1, TFF2, TBC1D30, SLC2A1) were identified for liver hepatocellular carcinoma.
- SLC2A1 and TFF2 are highly expressed in epithelial cells of tumor groups compared to non-tumor groups.
- Silencing SLC2A1 significantly reduces liver cancer cell migration and invasion.

## Abstract

Background: Hepatocellular carcinoma (LIHC) is a highly prevalent and poorly prognostic malignancy worldwide, and nutrient deprivation in the tumor microenvironment activates the starvation response in tumor cells. Starvation response-related genes (SRRGs) play critical roles in maintaining energy metabolism and promoting tumor development, but their value in prognostic prediction of LIHC has not been clarified.

Methods: We based on public databases to obtain transcriptome and single-cell RNA sequencing (scRNA-seq) data for LIHC and SRRG from previous studies. Key modules relevant to SRRGs were identified by weighted gene co-expression network analysis (WGCNA). Functional enrichment analysis was conducted using clusterProfiler R package. Independent prognostic genes were screened to build a RiskScore model and its performance was further verified. The immune microenvironmental profile of patients in different risk groups was assessed using the single-sample gene set enrichment analysis (ssGSEA), MCP-Counter, ESTIMATE, and TIMER algorithms. Seurat package for single-cell profiling and validation of key gene expression based on Huh7 and transformed human liver epithelial-2 (THLE-2) cell lines. The LIHC cell migration and invasion were measured by conducting wound healing and transwell assays.

Results: The key module identified by WGCNA showed the strongest correlation with SRRGs and the glycolysis-related SRRGs were mainly enriched in metabolism-correlated pathways. Two protective genes (FBXL5 and PON1) and three risk genes (TFF2, TBC1D30, and SLC2A1) were discovered as the independent prognostic genes for LIHC. Activation of cytokine–cytokine receptor interaction and IL-17 signaling pathway and higher infiltration of immune cells in high-risk group was observed. The five independent prognostic genes were mainly expressed in cancer stem cells and epithelial cells, in particular, SLC2A1 and TFF2 were significantly high-expressed in epithelial cells in the tumor group than in nontumor group. FBXL5 and PON1 were downregulated, while TFF2, TBC1D30, and SLC2A1 were upregulated in LIHC cells. Silencing SLC2A1 significantly inhibited LIHC cell migration and invasion.

Conclusion: In this study, we constructed the first risk model based on SRRGs to accurately predict the prognosis of LIHC, which provides a new idea for individualized treatment and targeted intervention.

## Linked entities

- **Genes:** FBXL5 (F-box and leucine rich repeat protein 5) [NCBI Gene 26234], PON1 (paraoxonase 1) [NCBI Gene 5444], TFF2 (trefoil factor 2) [NCBI Gene 7032], TBC1D30 (TBC1 domain family member 30) [NCBI Gene 23329], SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513]
- **Diseases:** hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, PON1 (paraoxonase 1) [NCBI Gene 5444] {aka ESA, MVCD5, PON}, TFF2 (trefoil factor 2) [NCBI Gene 7032] {aka SML1, SP}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, TBC1D30 (TBC1 domain family member 30) [NCBI Gene 23329], FBXL5 (F-box and leucine rich repeat protein 5) [NCBI Gene 26234] {aka CC2D2A-AS1, FBL4, FBL5, FLR1}
- **Diseases:** cancer (MESH:D009369), Hepatocellular carcinoma (MESH:D006528)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Huh7 — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0336), THLE-2 — Homo sapiens (Human), Transformed cell line (CVCL_3803)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12259329/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12259329/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12259329/full.md

---
Source: https://tomesphere.com/paper/PMC12259329